Visiomed Group (XPAR:ALVMG) Debt-to-Equity : 0.33 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group Debt-to-Equity?

Visiomed Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.29 Mil. Visiomed Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €7.64 Mil. Visiomed Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €24.10 Mil. Visiomed Group's debt to equity for the quarter that ended in Dec. 2023 was 0.33.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Visiomed Group's Debt-to-Equity or its related term are showing as below:

XPAR:ALVMG' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.59 Med: 0.23 Max: 7.67
Current: 0.33

During the past 13 years, the highest Debt-to-Equity Ratio of Visiomed Group was 7.67. The lowest was -0.59. And the median was 0.23.

XPAR:ALVMG's Debt-to-Equity is ranked worse than
61.78% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs XPAR:ALVMG: 0.33

Visiomed Group Debt-to-Equity Historical Data

The historical data trend for Visiomed Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group Debt-to-Equity Chart

Visiomed Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.59

0.35

0.23

0.33

Visiomed Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.35	-	0.23	0.36	0.33

Competitive Comparison of Visiomed Group's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Visiomed Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Visiomed Group's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visiomed Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Visiomed Group's Debt-to-Equity falls into.

Visiomed Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Visiomed Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.287	+	7.64)	/	24.102
	=	0.33

Visiomed Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.287	+	7.64)	/	24.102
	=	0.33

Visiomed Group (XPAR:ALVMG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Visiomed Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Visiomed Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Visiomed Group (XPAR:ALVMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

VMDGF:USA 7V91:Germany

Address

8, Avenue Kléber, Paris, FRA, 75116

Website

http://www.visiomed-lab.com

Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines